We performed the current study to examine expression of annexin II and S100A6 in surgical specimens of gastric carcinoma, to explore a possible correlation between annexin II and S100A6 expression and clinicopathological parameters, and to elucidate the clinical/prognostic value of annexin II and S100A6 in GC. Here, ANXA2 is linked to gastric carcinoma.